Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WOW
3051
DELISTED
WideOpenWest
WOW
| $2.25M | ﹤0.01% |
302,599
-16,342
| -5% | -$103K |
|
3052
Peloton Interactive
PTON
$2.44B
| $2.25M | ﹤0.01% |
+79,023
| New | +$2.13M |
|
|
IIN
3053
DELISTED
IntriCon Corporation
IIN
| $2.25M | ﹤0.01% |
124,726
-17,625
| -12% | -$338K |
|
3054
Spyre Therapeutics
SYRE
$8.98B
| $2.24M | ﹤0.01% |
11,749
-340
| -3% | -$66.7K |
|
|
MDLA
3055
DELISTED
Medallia, Inc.
MDLA
| $2.24M | ﹤0.01% |
72,133
+12,963
| +22% | +$383K |
|
3056
Verrica Pharmaceuticals
VRCA
$83.5M
| $2.24M | ﹤0.01% |
14,114
+480
| +4% | +$70.8K |
|
|
CBL
3057
DELISTED
CBL& Associates Properties, Inc.
CBL
| $2.24M | ﹤0.01% |
2,135,955
+50,184
| +2% | +$65.7K |
|
|
FNHC
3058
DELISTED
FedNat Holding Company Common Stock
FNHC
| $2.24M | ﹤0.01% |
134,654
-850
| -0.6% | -$12.7K |
|
3059
CrowdStrike
CRWD
$230B
| $2.24M | ﹤0.01% |
179,564
+18,832
| +12% | +$247K |
|
3060
Eastern Company
EML
$154M
| $2.24M | ﹤0.01% |
73,314
+2,800
| +4% | +$78.4K |
|
|
EMWP
3061
DELISTED
Eros Media World PLC
EMWP
| $2.24M | ﹤0.01% |
33,006
+224
| +0.7% | +$10.5K |
|
3062
Vanguard Health Care ETF
VHT
$19B
| $2.24M | ﹤0.01% |
11,662
-7,050
| -38% | -$1.26M |
|
3063
BCB Bancorp
BCBP
$163M
| $2.23M | ﹤0.01% |
162,092
-6,630
| -4% | -$88K |
|
|
ACH
3064
DELISTED
Alum Corp of China Ltd
ACH
| $2.23M | ﹤0.01% |
257,088
-103,862
| -29% | -$826K |
|
|
AKTS
3065
DELISTED
Akoustis Technologies Inc
AKTS
| $2.23M | ﹤0.01% |
278,869
-6,036
| -2% | -$47.2K |
|
|
MRSN
3066
DELISTED
Mersana Therapeutics
MRSN
| $2.23M | ﹤0.01% |
15,545
+10
| +0.1% | +$731 |
|
3067
Liquidity Services
LQDT
$1.35B
| $2.22M | ﹤0.01% |
372,201
-18,629
| -5% | -$120K |
|
|
SBBX
3068
DELISTED
SB One Bancorp Common Stock
SBBX
| $2.22M | ﹤0.01% |
89,034
-6,521
| -7% | -$151K |
|
3069
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $2.22M | ﹤0.01% |
19,363
+346
| +2% | +$39.1K |
|
|
BOCH
3070
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $2.22M | ﹤0.01% |
191,613
+3,976
| +2% | +$44.9K |
|
3071
Grupo Aeroportuario Centro Norte
OMAB
$5.19B
| $2.21M | ﹤0.01% |
36,970
-221
| -0.6% | -$12.1K |
|
3072
Lexicon Pharmaceuticals
LXRX
$1.04B
| $2.21M | ﹤0.01% |
533,543
+9,102
| +2% | +$35K |
|
3073
C&F Financial
CFFI
$288M
| $2.21M | ﹤0.01% |
39,981
+548
| +1% | +$29.2K |
|
|
UBX
3074
DELISTED
Unity Biotechnology
UBX
| $2.21M | ﹤0.01% |
30,657
+1,599
| +6% | +$113K |
|
|
SLCT
3075
DELISTED
Select Bancorp, Inc.
SLCT
| $2.2M | ﹤0.01% |
178,919
-14,077
| -7% | -$166K |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.